先进急诊医学

UGP2 与消化道肿瘤关系的研究现况

李 林涛

右江民族医学院研究生学院

黄 许森

右江民族医学院附属医院胃肠与腹壁疝外科

DOI: https://doi.org/10.59429/xjjz.v6i4.8629

Keywords: UGP2；消化道肿瘤；能量代谢；研究现况

---

Abstract

肿瘤严重威胁着人类的生活和健康，肿瘤细胞的生长增殖离不开细胞代谢的能量供应，UGP2 作为核苷酸代 谢中的关键酶在肿瘤细胞的发展过程中发挥着重要作用，并在人体多个器官组织中表达，其中骨骼肌中表达最高， 肝脏次之，另外在心脏、肾脏、胃等均有不同程度表达。有研究表明，UGP2 与多种肿瘤均有着密切关联，论文将对 UGP2 与消化道肿瘤的关系研究现况做一综述。

---

References

[1] 国家卫健委中国结直肠癌诊疗规范(2023版)[J].中国实用外科杂志,2023,43(6):602-630.

[2] Figueroa CM, Lunn JE, Iglesias AA. Nucleotide-sugar metabolism in plants: the legacy of Luis F. Leloir[J]. J Exp Bot,2021, 72(11):4053-4067.

[3] 车安然.P2Y14对肿瘤微环境中T细胞的调控功能研究[D].上海:华东师范大学,2022.

[4] 胃癌诊治难点中国专家共识(2020版)[J].中国实用外科杂志,2020,40(8):869-904.

[5] 罗婷,杜彦,段杰,等.开发和验证基于9个糖酵解相关基因的胃癌预后预测评分系统[J].癌症研究与治疗技术,2020:19.

[6] Mo X, Wu Y, Chen L, et al. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker[J]. J Clin Lab Anal,2019,33(2):22692.

[7] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.

[8] Hu Q, Shen S, Li J, et al. Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma[J]. Dis Markers,2020(11):3231273.

[9] WU Y. Identification of Protein-Coding Gene Markers in Breast Invasive Carcinoma Based on Machine Learning[J]. Acta Academiae Medicinae Sinicae,2024,46(2):147-153.

[10] Hu J, Song C. LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma[J]. Scientific Reports,2017,5(58):97835-97850.

[11] Wang L, Xiong L, Wu Z, et al. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance[J]. World J Surg Oncol,201816(1):11.

[12] 李茂岚,刘颖斌.胆道恶性肿瘤临床研究进展与展望[J].中国实用外科杂志,2020,40(2):167-170.

[13] Wang Q, Yang ZL, Zou Q, et al. SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer[J]. Cancer Invest,2016,34(6):255-64.

[14] 贺心怡,汤丁越,张洁,等.基于KRAS突变肽段介导的胰腺癌免疫治疗[J/OL].华东理工大学学报(自然科学版),1-11[2024-10-27].

[15] 赵梓楠,王国年.SOX4在消化系统恶性肿瘤中的研究进展[J].实用肿瘤学杂志,2022,36(4):364-368.

[16] Li Y, Zhuang H, Zhang X, et al. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma[J]. Mol Cell Proteomics,2018,17(4):607-618.

[17] Wolfe AL, Zhou Q, Toska E, et al. UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth[J]. Proc Natl Acad Sci U S A,2021,118(31):e2103592118.

[18] 卢恒哲,莫中成,邱媛,等.肿瘤相关巨噬细胞与结直肠癌:从机制到治疗的研究进展[J].现代肿瘤医学,2024,32(22):4366-4372.

[19] Dekker E, Tanis P J, Vleugels J L A, et al. Colorectal cancer [J]. Lancet,2019,394(10207):1467-1480.

[20] Thorsen K. Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis[J]. BMC Genomics,2011(12):505.

[21] 田悦.UGP2在结直肠癌中的表达及临床病理意义[D].百色:右江民族医学院,2022.